cover
Article Per Year (5 Year)
All
Home Page
OAI Link
Editorial Team
Contact
Reviewer
Google Scholar
Contact Name
-
Contact Email
-
Phone
-
Journal Mail Official
-
Editorial Address
-
Location
Kab. sleman,
Daerah istimewa yogyakarta
INDONESIA
JURNAL MANAJEMEN DAN PELAYANAN FARMASI (Journal of Management and Pharmacy Practice)
Published by Universitas Gadjah Mada
ISSN : 20888139     EISSN : 24432946     DOI : -
Core Subject : Health,
Health Professions Medicine & Pharmacology Public Health
JMPF is the first open access journal in Indonesia specialized in both research of pharmaceutical management and pharmacy practice. Articles submitted in JMPF are peer reviewed, we accept review articles and original research articles with no submission/publication fees. JMPF receives manuscripts in both English (preferably) and Indonesian Language (Bahasa Indonesia) with abstracts in bilingual, both Indonesian and English. JMPF is also open for various fields such as pharmaceutical management, pharmacoeconomics, pharmacoepidemiology, clinical pharmacy, community pharmacy, social pharmacy, pharmaceutical marketing, goverment policies related to pharmacy, and pharmaceutical care.
Arjuna Subject : -
Articles 5 Documents
 1 
Search results for , issue "Vol 8, No 2" : 5 Documents clear
Evaluating Inhaler Use Technique among Asthma and COPD Patients at a Primary Health Care Unit: A Pilot Study in Selangor Malaysia Zulfan Zazuli; Kogilavani Ramasamy; I Ketut Adnyana
JURNAL MANAJEMEN DAN PELAYANAN FARMASI (Journal of Management and Pharmacy Practice) Vol 8, No 2
Publisher : Faculty of Pharmacy, Universitas Gadjah Mada

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22146/jmpf.33829

Abstract

Inhaler is the most preferable device to deliver medication in order to treat asthma and Chronic Obstructive Pulmonary Disease (COPD). Incorrect usage of inhaler influences the clinical effectiveness of the delivered drug. A pilot study was conducted to determine the appropriateness of inhaler handling technique among asthma and COPD patients. As many as 92 subjects whom diagnosed with asthma and COPD, aged between 18 to 64 years old were observed in this cross-sectional study. Consenting subjects on inhaler, who attended medical out patients clinic at a primary health care unit in Selangor, Malaysia were asked to demonstrate on how they use the inhaler while an inhaler administration checklist were used to assess each patients inhaler technique. Data was analysed using descriptive statistical methods. Of total 92 patients, a total of 155 devices were used. Only 4 out of 92 patients correctly handles the device (4.3%). In average, a patient made approximately >4 mistakes during pMDI inhalation and >2 mistakes during DPI inhalation. The most common mistake found among pMDI, Turbuhaler and Accuhaler users were unable to hold the breath for approximately 5 seconds in which comprise of ≥80% patients. In conclusion, majority of asthma and COPD patients use their inhaler inaccurately. Patients prescribed by inhalation medications should have routine assessment of their inhaler technique at every visit and corrected if found to be poor.
Description of Professional Fee for Pharmacist in Sleman Hardika Aditama; A. Saputri; D. Fadhilah; K. Mayningrum; A. Sawitri; W.A. Pratiwi; I.N. Pristhifani
JURNAL MANAJEMEN DAN PELAYANAN FARMASI (Journal of Management and Pharmacy Practice) Vol 8, No 2
Publisher : Faculty of Pharmacy, Universitas Gadjah Mada

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22146/jmpf.34062

Abstract

Pharmacist is a profession whose existence is needed by community. However, within the community of pharmacy itself, the presence of pharmacist is quite alarming. One of the causes of low pharmacist who desire to practice in the community of pharmacy is the low level of professional fee offered. This study aimed to describe professional fee received by pharmacist and the workload of pharmacist in Sleman. This study was a descriptive non-experimental that was conducted in Sleman in August 2017. Population of this study was a pharmacist who practiced in community of pharmacy in Sleman. Total of 170 respondents from 128 pharmacies were involved in this research. However, 6 questionnaires cannot be analyzed because it is not completely filled. The highest amount of professional fee is between Rp 2.000.000-Rp 3.000.000. Almost all respondents (78%) stated the amount of professional fee that was received was not as expected. The workload of pharmacists is not so heavy and most of the patient are self medication. Pharmacists at the community of pharmacy should be able to show a better work performace, which is shown by increasing pharmacy revenues to get a better rewards.
Five Methods Comparison of 10 Years Cardiovascular Disease Risk Estimation in the Community in Sleman-Yogyakarta Clarentia Dwivani; Herlina Herlina; Karina Harijadi; Budianto Budianto; Rita Suhadi
JURNAL MANAJEMEN DAN PELAYANAN FARMASI (Journal of Management and Pharmacy Practice) Vol 8, No 2
Publisher : Faculty of Pharmacy, Universitas Gadjah Mada

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22146/jmpf.34469

Abstract

Cardiovascular disease is the highest cause of death with total of 17.5 million deaths in the world. Nowadays there have beenexists many methods to calculate the risk of cardiovascular disease within the next 10 years, 5 of them are Framingham Risk Score (FRS) BMI and Cholesterol, Pooled Cohort Equations (PCE), CV Risk Calculator, and Systematic Coronary Risk Evaluation (SCORE). The aim of this study waiss to compare the 5 methods of 10-year risk of cardiovascular disease based on mean values, risk categories, and statin recommendation. This observational analytic study was done with cross-sectional design. There were 169 respondents in Sleman, Yogyakarta who participated to this study. Normality of risk measurement data was performed using Kolmogorov-Smirnov test and comparative test was performed using Repeated ANOVA. Both proportion of risk categorization and statin therapy was calculated using the Marginal Homogeneity test. The average risk of  FRS (BMI and Cholesterol), PCE, CV Risk Calculator, and SCORE were 14,6±11,7% (medium risk), 13,3±11,3% (medium risk), 6,8±6,4% (medium risk), 6,8±6,4% (medium risk), and 2,6±3,5% (medium risk).  There were significant differences from the comparison between among methods on mean values and risk categories (p <0.01), except on PCE with FRS BMI (p=0.11) and PCE with CVRiskcalculator (p = 1.00). Comparison of statin therapy recommendation among FRS Cholesterol with PCE, FRS Cholesterol with SCORE, and PCE with FRS BMI methods showed significant differences (p <0.01), whereas FRS Cholesterol with FRS BMI and PCE with SCORE were not significantly different (p = 0,06 and p = 0,05).
Factors Affecting Non-Adherence to Secondary Stroke Prevention Therapy in Ischemic Stroke Patients Zakky Cholisoh; Hidayah Karuniawati; Tanti Azizah; Zaenab Zaenab; Laila Nur Hekmah
JURNAL MANAJEMEN DAN PELAYANAN FARMASI (Journal of Management and Pharmacy Practice) Vol 8, No 2
Publisher : Faculty of Pharmacy, Universitas Gadjah Mada

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22146/jmpf.34434

Abstract

Stroke is cardiovascular disease that causes the world's highest disability and is the most prevalence disease after heart disease and cancer. Stroke is caused by circulatory disorders with 80% of the sufferers are diagnosed with ischemic stroke and 20% of them are diagnosed with hemorrhagic stroke. Patients who survive from the first stroke have high risk to have recurrent stroke. American Heart Association/American Stroke Association and Perhimpunan Dokter Spesialis Syaraf Indonesia recommend secondary stroke prevention therapy including antiplatelet/anticoagulant, antihypertensive agents, and antidislipidemia to minimalize the risk of recurrent stroke. Secondary stroke prevention therapy is only the first step. Patients need to be adhere to those therapies. The non-adherence will increase the risk of recurrent stroke. The study aimed to determine factors which causing the non-adherence to secondary prevention therapy in patients with ischemic stroke. This was a case control study with concecutive sampling method by interviewing patients who met the inclusion criterias i.e., had been diagnosed and were inpatients due to ischemic stroke, but in the time of interview patients were outpatients, patients were able to communicate and agree to participate in the study.Data was analized by bivariate / chi square test and multivariate logistic regression test. During the study period, 184 respondents met the inclusion criterias. Factors affecting non-adherence in the use of secondary prevention therapy were No one reminded to take medicine p = 0.03; OR 4.51, denial of the disease p = 0,036 OR 214, and tired of taking medicine p = 0,045 OR 1,97.
Cost Effectiveness Analysis of Crystalloid and Crystaloid-Colloid Combination on Dengue Fever without Shok in Bhakti Asih General Hospital Tangerang Suratni Suratni; Yusi Anggriani; Agusdini Banun
JURNAL MANAJEMEN DAN PELAYANAN FARMASI (Journal of Management and Pharmacy Practice) Vol 8, No 2
Publisher : Faculty of Pharmacy, Universitas Gadjah Mada

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22146/jmpf.33367

Abstract

Dengue fever is an infectious disease caused by virus transmitted through Aedes aegypty. The high incidence dengue fever can lead to increased healthcare costs. This study was conducted to analyze the effectiveness and direct cost of medical patients dengue fever without shock use fluid therapy by comparing crystalloid and crystalloid colloid combination. The subjects were 171 patients divided into two groups: 106 patients with crystalloid and 65 patients with crystalloid colloid combination. Assessed of effectiveness treatment and the mean medical costs. The results showed reviewed from hematocrit value no difference (p>0.05) in both study groups. The mean total cost of treatment for crystalloid Rp 4.005.223, the crystalloid colloid combination Rp 5.525.407. The highest cost of drug costs was 31.75% of the total cost crystalloid, 40.9% of the total cost crystalloid colloid combination. There was a significant difference between mean cost and two study groups (p0.05) with effectiveness treatment. Conclusion crystalloid have the same effectiveness as crystalloid colloid combination fluids at lower costs.

Page 1 of 1 | Total Record : 5

 1 

Filter by Year

0000


Reset
Filter By Issues
All Issue Vol 15, No 3 Vol 15, No 2 Vol 15, No 1 Vol 14, No 4 Vol 14, No 3 Vol 14, No 2 Vol 14, No 1 Vol 13, No 4 Vol 13, No 3 Vol 13, No 2 Vol 13, No 1 Vol 12, No 4 Vol 12, No 3 Vol 12, No 2 Vol 12, No 1 Vol 11, No 4 Vol 11, No 2 Vol 1, No 3 Vol 11, No 3 Vol 11, No 1 Vol 10, No 4 Vol 10, No 3 Vol 10, No 2 Vol 10, No 1 Vol 9, No 4 Vol 9, No 3 Vol 9, No 2 Vol 9, No 1 Vol 8, No 4 Vol 8, No 3 Vol 8, No 2 Vol 8, No 1 Vol 7, No 4 Vol 7, No 3 Vol 7, No 2 Vol 7, No 1 Vol 6, No 4 Vol 6, No 3 Vol 6, No 2 Vol 6, No 1 Vol 5, No 4 Vol 5, No 4 Vol 5, No 3 Vol 5, No 3 Vol 5, No 2 Vol 5, No 1 Vol 4, No 4 Vol 4, No 3 Vol 4, No 2 Vol 4, No 1 Vol 3, No 4 Vol 3, No 3 Vol 3, No 2 Vol 3, No 1 Vol 2, No 4 Vol 2, No 3 Vol 2, No 2 Vol 2, No 1 Vol 1, No 4 Vol 1, No 2 Vol 1, No 1 More Issue